WS Industries (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 11, 2025, 12:10 am

Competitors of WS Industries (India) Ltd

All Competitor Stocks of WS Industries (India) Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:15 am

Below is a detailed analysis of the quarterly data for WS Industries (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 26.05 Cr.. The value appears to be declining and may need further review. It has decreased from 39.67 Cr. (Mar 2025) to 26.05 Cr., marking a decrease of 13.62 Cr..
• For Expenses, as of Jun 2025, the value is 22.75 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 40.04 Cr. (Mar 2025) to 22.75 Cr., marking a decrease of 17.29 Cr..
• For Operating Profit, as of Jun 2025, the value is 3.30 Cr.. The value appears strong and on an upward trend. It has increased from -0.37 Cr. (Mar 2025) to 3.30 Cr., marking an increase of 3.67 Cr..
• For OPM %, as of Jun 2025, the value is 12.67%. The value appears strong and on an upward trend. It has increased from -0.93% (Mar 2025) to 12.67%, marking an increase of 13.60%.
• For Other Income, as of Jun 2025, the value is 1.08 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.08 Cr..
• For Interest, as of Jun 2025, the value is 2.16 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.30 Cr. (Mar 2025) to 2.16 Cr., marking a decrease of 0.14 Cr..
• For Depreciation, as of Jun 2025, the value is 0.44 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.55 Cr. (Mar 2025) to 0.44 Cr., marking a decrease of 0.11 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.78 Cr.. The value appears strong and on an upward trend. It has increased from -2.14 Cr. (Mar 2025) to 1.78 Cr., marking an increase of 3.92 Cr..
• For Tax %, as of Jun 2025, the value is 23.60%. The value appears to be increasing, which may not be favorable. It has increased from -22.90% (Mar 2025) to 23.60%, marking an increase of 46.50%.
• For Net Profit, as of Jun 2025, the value is 1.36 Cr.. The value appears strong and on an upward trend. It has increased from -1.65 Cr. (Mar 2025) to 1.36 Cr., marking an increase of 3.01 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.23. The value appears strong and on an upward trend. It has increased from -0.24 (Mar 2025) to 0.23, marking an increase of 0.47.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:27 pm

Growth

Last Updated: September 5, 2025, 1:51 pm

Balance Sheet

Last Updated: July 25, 2025, 2:04 pm

Below is a detailed analysis of the balance sheet data for WS Industries (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 50.00 Cr. (Mar 2024) to 63.00 Cr., marking an increase of 13.00 Cr..
• For Reserves, as of Mar 2025, the value is 135.00 Cr.. The value appears strong and on an upward trend. It has increased from 87.00 Cr. (Mar 2024) to 135.00 Cr., marking an increase of 48.00 Cr..
• For Borrowings, as of Mar 2025, the value is 87.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 74.00 Cr. (Mar 2024) to 87.00 Cr., marking an increase of 13.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 123.00 Cr.. The value appears to be improving (decreasing). It has decreased from 138.00 Cr. (Mar 2024) to 123.00 Cr., marking a decrease of 15.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 409.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 349.00 Cr. (Mar 2024) to 409.00 Cr., marking an increase of 60.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 154.00 Cr.. The value appears strong and on an upward trend. It has increased from 151.00 Cr. (Mar 2024) to 154.00 Cr., marking an increase of 3.00 Cr..
• For CWIP, as of Mar 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 3.00 Cr., marking an increase of 3.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 252.00 Cr.. The value appears strong and on an upward trend. It has increased from 198.00 Cr. (Mar 2024) to 252.00 Cr., marking an increase of 54.00 Cr..
• For Total Assets, as of Mar 2025, the value is 409.00 Cr.. The value appears strong and on an upward trend. It has increased from 349.00 Cr. (Mar 2024) to 409.00 Cr., marking an increase of 60.00 Cr..

Notably, the Reserves (135.00 Cr.) exceed the Borrowings (87.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for WS Industries (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -3.08. This value is below the healthy minimum of 5. It has decreased from 10.00 (Mar 24) to -3.08, marking a decrease of 13.08.
• For Diluted EPS (Rs.), as of Mar 25, the value is -3.08. This value is below the healthy minimum of 5. It has decreased from 9.24 (Mar 24) to -3.08, marking a decrease of 12.32.
• For Cash EPS (Rs.), as of Mar 25, the value is -2.48. This value is below the healthy minimum of 3. It has decreased from 9.47 (Mar 24) to -2.48, marking a decrease of 11.95.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 31.31. It has increased from 23.32 (Mar 24) to 31.31, marking an increase of 7.99.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 31.31. It has increased from 27.31 (Mar 24) to 31.31, marking an increase of 4.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 37.72. It has decreased from 64.85 (Mar 24) to 37.72, marking a decrease of 27.13.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 2.34. This value is within the healthy range. It has decreased from 8.66 (Mar 24) to 2.34, marking a decrease of 6.32.
• For PBIT / Share (Rs.), as of Mar 25, the value is 2.02. This value is within the healthy range. It has decreased from 8.52 (Mar 24) to 2.02, marking a decrease of 6.50.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.73. This value is within the healthy range. It has decreased from 7.22 (Mar 24) to 0.73, marking a decrease of 6.49.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -2.80. This value is below the healthy minimum of 2. It has decreased from 9.33 (Mar 24) to -2.80, marking a decrease of 12.13.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -2.77. This value is below the healthy minimum of 2. It has decreased from 9.33 (Mar 24) to -2.77, marking a decrease of 12.10.
• For PBDIT Margin (%), as of Mar 25, the value is 6.20. This value is below the healthy minimum of 10. It has decreased from 13.35 (Mar 24) to 6.20, marking a decrease of 7.15.
• For PBIT Margin (%), as of Mar 25, the value is 5.35. This value is below the healthy minimum of 10. It has decreased from 13.13 (Mar 24) to 5.35, marking a decrease of 7.78.
• For PBT Margin (%), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 10. It has decreased from 11.13 (Mar 24) to 1.94, marking a decrease of 9.19.
• For Net Profit Margin (%), as of Mar 25, the value is -7.42. This value is below the healthy minimum of 5. It has decreased from 14.38 (Mar 24) to -7.42, marking a decrease of 21.80.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -7.35. This value is below the healthy minimum of 8. It has decreased from 14.38 (Mar 24) to -7.35, marking a decrease of 21.73.
• For Return on Networth / Equity (%), as of Mar 25, the value is -8.85. This value is below the healthy minimum of 15. It has decreased from 39.99 (Mar 24) to -8.85, marking a decrease of 48.84.
• For Return on Capital Employeed (%), as of Mar 25, the value is 4.62. This value is below the healthy minimum of 10. It has decreased from 20.73 (Mar 24) to 4.62, marking a decrease of 16.11.
• For Return On Assets (%), as of Mar 25, the value is -4.30. This value is below the healthy minimum of 5. It has decreased from 13.44 (Mar 24) to -4.30, marking a decrease of 17.74.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.29. This value is within the healthy range. It has decreased from 0.40 (Mar 24) to 0.29, marking a decrease of 0.11.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has decreased from 0.60 (Mar 24) to 0.42, marking a decrease of 0.18.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.63. It has decreased from 1.11 (Mar 24) to 0.63, marking a decrease of 0.48.
• For Current Ratio (X), as of Mar 25, the value is 1.53. This value is within the healthy range. It has increased from 1.22 (Mar 24) to 1.53, marking an increase of 0.31.
• For Quick Ratio (X), as of Mar 25, the value is 1.45. This value is within the healthy range. It has increased from 1.08 (Mar 24) to 1.45, marking an increase of 0.37.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.63. This value is within the healthy range. It has decreased from 14.86 (Mar 24) to 7.63, marking a decrease of 7.23.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.82. This value is below the healthy minimum of 3. It has decreased from 7.30 (Mar 24) to 1.82, marking a decrease of 5.48.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.18. This value is below the healthy minimum of 3. It has decreased from 8.95 (Mar 24) to -1.18, marking a decrease of 10.13.
• For Enterprise Value (Cr.), as of Mar 25, the value is 497.10. It has decreased from 782.59 (Mar 24) to 497.10, marking a decrease of 285.49.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.08. This value is within the healthy range. It has decreased from 2.40 (Mar 24) to 2.08, marking a decrease of 0.32.
• For EV / EBITDA (X), as of Mar 25, the value is 33.52. This value exceeds the healthy maximum of 15. It has increased from 17.96 (Mar 24) to 33.52, marking an increase of 15.56.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.87. This value is within the healthy range. It has decreased from 2.30 (Mar 24) to 1.87, marking a decrease of 0.43.
• For Price / BV (X), as of Mar 25, the value is 2.25. This value is within the healthy range. It has decreased from 6.39 (Mar 24) to 2.25, marking a decrease of 4.14.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.87. This value is within the healthy range. It has decreased from 2.30 (Mar 24) to 1.87, marking a decrease of 0.43.
• For EarningsYield, as of Mar 25, the value is -0.03. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to -0.03, marking a decrease of 0.09.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness